This inventor holds 1 USPTO granted patent. Top assignee: Georgia Tech Research Corporation. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Neal McCarty: Innovator in ClC Channel Research
Introduction
Neal McCarty is an accomplished inventor based in Atlanta, GA. He has made significant contributions to the field of pharmaceutical compositions, particularly in the area of ClC channels. His innovative work focuses on methods for inhibiting the CLC-2 channel using GATX2.
Latest Patents
Neal McCarty holds a patent titled "Methods for inhibiting CLC-2 channel with GATX2." This patent involves compositions and methods utilizing a scorpion venom peptide that acts as a ligand for ClC channels. One key aspect of his invention is a pharmaceutical composition containing an effective amount of GaTx2 to inhibit ClC activity. Additionally, the patent outlines methods for treating disorders related to aberrant ClC channel activity.
Career Highlights
Neal McCarty is affiliated with the Georgia Tech Research Corporation, where he continues to advance his research and innovation in the field. His work has the potential to impact various medical conditions linked to ClC channel dysfunction.
Collaborations
Neal has collaborated with notable colleagues, including Christopher H. Thompson and Julia M. Kubanek, enhancing the scope and depth of his research endeavors.
Conclusion
Neal McCarty's contributions to the understanding and treatment of ClC channel-related disorders highlight his role as a key innovator in the field. His patent and ongoing research at Georgia Tech Research Corporation demonstrate his commitment to advancing medical science.